Profile of pazopanib and its potential in the treatment of epithelial ovarian cancer

Por Davidson, Brittany A, Secord, Angeles Alvarez
Publicado em 2014

Quinary debulking for epithelial ovarian cancer

Por Edwards, James M., Lowery, William Jeffrey, Secord, Angeles Alvarez
Publicado em 2012

Severe ulceration over mandibular torus in an ovarian cancer patient receiving bevacizumab therapy

Por Teoh, Deanna, Won, John S., Eisberg, Robert, Nolte, Kimberly, Secord, Angeles Alvarez
Publicado em 2011

Metastatic adenocarcinoma after laparoscopic supracervical hysterectomy with morcellation: A case report()

Por Turner, Taylor, Secord, Angeles Alvarez, Lowery, William J., Sfakianos, Gregory, Lee, Paula S.
Publicado em 2013

Recurrent granulosa cell tumor presenting with spontaneous retroperitoneal hemorrhage: A case report

Por Zani, Sabino, Stoecker, Maggie, Cox, Mitchell W., Secord, Angeles Alvarez, Blazer, Dan G.
Publicado em 2011

Adenocarcinoma of Mullerian origin: review of pathogenesis, molecular biology, and emerging treatment paradigms

Por Cobb, Lauren Patterson, Gaillard, Stephanie, Wang, Yihong, Shih, Ie-Ming, Secord, Angeles Alvarez
Publicado no Gynecol Oncol Res Pract (2015)

Robotic-Assisted Laparoscopic Gynecologic Procedures in a Fellowship Training Program

Por Lee, Paula S., Bland, Amy, Valea, Fidel A., Havrilesky, Laura J., Berchuck, Andrew, Secord, Angeles Alvarez
Publicado em 2009

Autoantibody biomarkers identified by proteomics methods distinguish ovarian cancer from non ovarian cancer with various CA-125 levels

Por Karabudak, Aykan, Hafner, Julie, Shetty, Vivekananda, Chen, Songming, Secord, Angeles Alvarez, Morse, Michael, Philip, Ramila
Publicado em 2013

Analysis of in vitro chemoresponse assays in endometrioid endometrial adenocarcinoma: an observational ancillary analysis

Por Davidson, Brittany A., Foote, Jonathan, Brower, Stacey L., Tian, Chunqiao, Havrilesky, Laura J., Secord, Angeles Alvarez
Publicado no Gynecol Oncol Res Pract (2016)

Dasatinib (BMS-35482) interacts synergistically with docetaxel, gemcitabine, topotecan and doxorubicin in ovarian cancer cells with high SRC pathway activation and protein expressi...

Por Teoh, Deanna, Jia, Jingquan, Nixon, Andrew B., Grace, Lisa, Adams, David J., Murphy, Susan K., Secord, Angeles Alvarez
Publicado em 2014

Dasatinib (BMS-35482) potentiates the activity of gemcitabine and docetaxel in uterine leiomyosarcoma cell lines

Por Lopez-Acevedo, Micael, Grace, Lisa, Teoh, Deanna, Whitaker, Regina, Adams, David J, Jia, Jingquan, Nixon, Andrew B, Secord, Angeles Alvarez
Publicado no Gynecol Oncol Res Pract (2014)

Phase II Trial of Cetuximab and Carboplatin in Relapsed Platinum-Sensitive Ovarian Cancer and Evaluation of Epidermal Growth Factor Receptor Expression: A Gynecologic Oncology Grou...

Por Secord, Angeles Alvarez, Blessing, John A., Armstrong, Deborah K., Rodgers, William H., Miner, Zoe, Barnes, Mack N., Lewandowski, George, Mannel, Robert S.
Publicado em 2008

BRCA1 Immunohistochemistry in a Molecularly Characterized Cohort of Ovarian Carcinomas

Por Garg, Karuna, Levine, Douglas A, Olvera, Narciso, Dao, Fanny, Bisogna, Maria, Secord, Angeles Alvarez, Berchuck, Andrew, Cerami, Ethan, Schultz, Nikolaus, Soslow, Robert A
Publicado em 2013

Performance of sentinel lymph node biopsy in high-risk endometrial cancer

Por Ehrisman, Jessie, Secord, Angeles Alvarez, Berchuck, Andrew, Lee, Paula S., Di Santo, Nicola, Lopez-Acevedo, Micael, Broadwater, Gloria, Valea, Fidel A., Havrilesky, Laura J.
Publicado no Gynecol Oncol Rep (2016)

A phase I trial of dasatinib, a Src-family kinase Inhibitor, in combination with paclitaxel and carboplatin in patients with advanced or recurrent ovarian cancer

Por Secord, Angeles Alvarez, Teoh, Deanna K., Barry, William T., Yu, Miao, Broadwater, Gloria, Havrilesky, Laura J., Lee, Paula S., Berchuck, Andrew, Lancaster, Johnathan, Wenham, Robert M.
Publicado em 2012

Obesity is associated with worse overall survival in women with low grade papillary serous epithelial ovarian cancer

Por Previs, Rebecca, Kilgore, Joshua, Craven, Renatta, Broadwater, Gloria, Bean, Sarah, Wobker, Sara, DiFurio, Megan, Bae-Jump, Victoria, Gehrig, Paola A., Secord, Angeles Alvarez
Publicado no Int J Gynecol Cancer (2014)

Lumbee Native American ancestry and the incidence of aggressive histologic subtypes of endometrial cancer

Por Zhang, Chelsea, Roque, Dario, Ehrisman, Jessie A., DiSanto, Nicola, Broadwater, Gloria, Doll, Kemi M., Gehrig, Paola A., Secord, Angeles Alvarez, Havrilesky, Laura J.
Publicado no Gynecol Oncol Rep (2015)

Expression signatures of TP53 mutations in serous ovarian cancers

Por Bernardini, Marcus Q, Baba, Tsukasa, Lee, Paula S, Barnett, Jason C, Sfakianos, Gregory P, Secord, Angeles Alvarez, Murphy, Susan K, Iversen, Edwin, Marks, Jeffrey R, Berchuck, Andrew
Publicado em 2010

Dasatinib (BMS-35482) has synergistic activity with paclitaxel and carboplatin in ovarian cancer cells

Por Teoh, Deanna, Ayeni, Tina A., Rubatt, Jennifer M., Adams, David J., Grace, Lisa, Starr, Mark D., Barry, William T, Berchuck, Andrew, Murphy, Susan K., Secord, Angeles Alvarez
Publicado em 2011

A multi-institutional study of outcomes in stage I–III uterine carcinosarcoma

Por Dickson, Elizabeth L., Vogel, Rachel Isaksson, Gehrig, Paola A., Pierce, Stuart, Havrilesky, Laura, Secord, Angeles Alvarez, Dottino, Joseph, Fader, Amanda N., Ricci, Stephanie, Geller, Melissa A.
Publicado no Gynecol Oncol (2015)